InsidersTradesSigma
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Pooler Amy. Director active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 5 filings have been published. History available since 25 November 2023. The latest transaction was filed on 24 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations